NeoGenesis Drug Discovery Inc., Mitsubishi-Tokyo Pharmaceuticals Inc. deal

NeoGenesis will use its automated ligand identification system to discover small molecules against targets provided by Mitsubishi-Tokyo. NeoGenesis will receive development funding and is eligible for...